| scholarly article | Q13442814 |
| P50 | author | Parish P. Sedghizadeh | Q39187404 |
| Marzenna Bartoszewicz | Q59687345 | ||
| Robert Graham G Russell | Q67903135 | ||
| Patrycja Szymczyk | Q85263743 | ||
| Keivan Sadrerafi | Q86934843 | ||
| Monika Oleksy | Q88664847 | ||
| P2093 | author name string | Charles E McKenna | |
| Frank H Ebetino | |||
| Jeffrey D Neighbors | |||
| Mark W Lundy | |||
| Shuting Sun | |||
| Eric Richard | |||
| Neema Bakhshalian | |||
| Adam F Junka | |||
| Susan Mahabady | |||
| Natalia Tjokro | |||
| P2860 | cites work | Osteomyelitis | Q33205211 |
| Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding | Q33556083 | ||
| Development of an animal model for Aggregatibacter actinomycetemcomitans biofilm-mediated oral osteolytic infection: a preliminary study | Q33790249 | ||
| The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. | Q33960800 | ||
| Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. | Q34009569 | ||
| Quinolones: a comprehensive review | Q34115365 | ||
| Drying of organic solvents: quantitative evaluation of the efficiency of several desiccants. | Q34143552 | ||
| pH-triggered intracellular release from actively targeting polymer micelles | Q34627898 | ||
| Organic carbamates in drug design and medicinal chemistry | Q35365543 | ||
| Orthopaedic biofilm infections | Q35738493 | ||
| Bisphosphonate uptake in areas of tooth extraction or periapical disease | Q35755688 | ||
| Chronic osteomyelitis increases long-term mortality risk in the elderly: a nationwide population-based cohort study. | Q35974401 | ||
| Biofilm bacteria: formation and comparative susceptibility to antibiotics | Q36500989 | ||
| Population pharmacokinetic and pharmacodynamic modeling for assessing risk of bisphosphonate-related osteonecrosis of the jaw. | Q36532868 | ||
| 'Magic bullets' for bone diseases: progress in rational design of bone-seeking medicinal agents | Q36746390 | ||
| Perturbation of the indigenous rat oral microbiome by ciprofloxacin dosing | Q37157745 | ||
| Aggregatibacter actinomycetemcomitans biofilm killing by a targeted ciprofloxacin prodrug | Q37281537 | ||
| A novel liposomal drug delivery system for PMMA bone cements | Q37371134 | ||
| Oral antibiotic treatment of staphylococcal bone and joint infections in adults | Q38144837 | ||
| Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success | Q38212925 | ||
| Local antibiotic delivery systems in diabetic foot osteomyelitis: time for one step beyond? | Q38325417 | ||
| Bisphosphonate-modified biomaterials for drug delivery and bone tissue engineering | Q38367669 | ||
| Understanding osteomyelitis and its treatment through local drug delivery system | Q38969920 | ||
| Hot melt poly-ε-caprolactone/poloxamine implantable matrices for sustained delivery of ciprofloxacin | Q39411105 | ||
| Ciprofloxacin concentrations in bone and muscle after oral dosing | Q39850877 | ||
| Linking bisphosphonates to the free amino groups in fluoroquinolones: preparation of osteotropic prodrugs for the prevention of osteomyelitis. | Q39932880 | ||
| Bisphosphonates: a review of their pharmacokinetic properties | Q41132404 | ||
| Microbial biofilms are able to destroy hydroxyapatite in the absence of host immunity in vitro. | Q41579307 | ||
| Synthesis and in vitro evaluation of bisphosphonated glycopeptide prodrugs for the treatment of osteomyelitis. | Q43185478 | ||
| Design, synthesis, and biological evaluation of novel estradiol-bisphosphonate conjugates as bone-specific estrogens. | Q43195387 | ||
| Osteoadsorptive bisphosphonate derivatives of fluoroquinolone antibacterials | Q43996444 | ||
| Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis | Q44454686 | ||
| Bisphosphonate-ciprofloxacin bound to Skelite is a prototype for enhancing experimental local antibiotic delivery to injured bone | Q45078826 | ||
| Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. | Q51777217 | ||
| Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro | Q78165206 | ||
| Comparative assessment of the antimicrobial susceptibility of Staphylococcus aureus isolates from bovine mastitis in biofilm versus planktonic culture | Q80162323 | ||
| Biofilms and chronic infections | Q81433584 | ||
| Synthesis of osteotropic hydroxybisphosphonate derivatives of fluoroquinolone antibacterials | Q82554528 | ||
| Design and synthesis of novel bone-targeting dual-action pro-drugs for the treatment and reversal of osteoporosis | Q83461788 | ||
| Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research | Q83572665 | ||
| Limb amputation and prosthesis | Q87306383 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biofilm | Q467410 |
| osteomyelitis | Q938983 | ||
| P304 | page(s) | 2326-2343 | |
| P577 | publication date | 2017-02-13 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Design, Synthesis, and Antimicrobial Evaluation of a Novel Bone-Targeting Bisphosphonate-Ciprofloxacin Conjugate for the Treatment of Osteomyelitis Biofilms | |
| P478 | volume | 60 |
| Q38610253 | Advances in the local and targeted delivery of anti-infective agents for management of osteomyelitis |
| Q55515922 | Bisphosphonate conjugation for bone specific drug targeting. |
| Q50300911 | Bisphosphonate-Linked TrkB Agonist: Cochlea-Targeted Delivery of a Neurotrophic Agent as a Strategy for the Treatment of Hearing Loss |
| Q55408804 | Construction of injectable, pH sensitive, antibacterial, mineralized amino acid yolk-shell microspheres for potential minimally invasive treatment of bone infection. |
| Q38667546 | Development of Bone Targeting Drugs. |
| Q50054915 | Effect of Low-Frequency Pulsed Ultrasound on Drug Delivery, Antibacterial Efficacy, and Bone Cement Degradation in Vancomycin-Loaded Calcium Phosphate Cement. |
| Q90913027 | Evolving concepts in bone infection: redefining "biofilm", "acute vs. chronic osteomyelitis", "the immune proteome" and "local antibiotic therapy" |
| Q48262033 | Interactions between Clinically Used Bisphosphonates and Bone Mineral: from Coordination Chemistry to Biomedical Applications and Beyond. |
| Q99591269 | Poly(Aspartic Acid) Functionalized Poly(ϵ-Caprolactone) Microspheres with Enhanced Hydroxyapatite Affinity as Bone Targeting Antibiotic Carriers |
| Q61800644 | Potential of Biocellulose Carrier Impregnated with Essential Oils to Fight Against Biofilms Formed on Hydroxyapatite |
| Q97542685 | The McKenna reaction - avoiding side reactions in phosphonate deprotection |
Search more.